Virbac Corporation

17 articles about Virbac Corporation

• Virbac Announces FDA Approval of New Cancer Treatment for Dogs Derived from Australian Rainforest Plant

  8/16/2021

  Virbac  announces the breakthrough drug STELFONTA ®  (tigilanol tiglate injection) that has been approved by the U.S. Food and Drug Administration (FDA) as a non-surgical alternative for treating canine mast cell tumors in dogs, is now available in veterinary clinics throughout the United States .

• Merck Animal Health to Acquire U.S. Rights to SENTINEL® Brand of Combination Parasiticides for Companion Animals

  5/13/2020

  Further Solidifies Merck Animal Health’s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection

• Vet Pharma Firm Virbac to Consolidate Warehousing And Distribution To New Facility In Kansas, Will Create New Jobs

  4/21/2017

• NovaBay Pharmaceuticals, Inc. and Virbac Corporation Enter Into a Collaboration and License Agreement for Animal Health

  5/28/2013

• NovaBay Pharmaceuticals, Inc. Signs Option Agreement With Virbac Corporation Animal Health for Aganocide(R) Compounds

  3/20/2012

• Virbac Corporation to Distribute Prevtec Microbia, Inc.'s Innovative Coliprotec(R) Vaccine In Brazil

  3/28/2011

• Virbac Corporation Exercises Its Options for a Commercial Licence Agreement to Use Vivalis' EBx(R) Platform

  4/1/2008

• ProBioGen AG and Virbac Corporation Signed a Licensing Agreement to use ProBioGen's Novel Avian Cell Line AGE1 for Production of Biological Products

  5/31/2007

• Virbac Corporation "Going Private" Transaction Completed; Company Now Wholly Owned By The Virco Group NV And Delisted From Nasdaq

  11/13/2006

• Virbac Corporation Announces Chief Financial Officer Resigns To Pursue Another Opportunity

  10/17/2006

• Special Committee Of Virbac Corporation Unanimously Approves Virbac S.A.'s Amended Tender Offer Price Of $5.75 Per Share

  10/13/2006

• Virbac Corporation Increases Offer For Publicly Held Shares Of Virbac S.A. To $5.75 Per Share And Extends Offer To October 31, 2006

  10/11/2006

• Virbac S.A. Further Extends Cash Tender Offer For All Publicly Held Shares Of Virbac Corporation

  10/4/2006

• Virbac S.A. Further Extends Cash Tender Offer For All Publicly Held Shares Of Virbac Corporation

  9/26/2006

• Virbac S.A. Commences Tender Offer For All Publicly Held Shares Of Virbac Corporation

  8/18/2006

• Virbac Corporation Announces Record Second Quarter Revenues of $25 Million And Record Quarterly Earnings Of $0.14 Per Share

  8/14/2006

• Virbac S.A. And Virbac Corporation Sign Tender Offer And Merger Agreement

  8/11/2006